Drug intelligence / Profile preview

budesonide

Development stage
Approved
Lead developer
AstraZeneca
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Inhalation, Intranasal, Rectal
01

Overview

Budesonide is a synthetic corticosteroid with potent anti-inflammatory properties. It acts primarily as a glucocorticoid receptor agonist and is used to treat various inflammatory diseases affecting the airways and gastrointestinal tract. Budesonide works by inhibiting multiple types of inflammatory cells (such as mast cells and eosinophils) and suppressing the release of inflammatory mediators like histamine and cytokines. It has high topical anti-inflammatory activity with minimal systemic effects due to extensive first-pass metabolism in the liver. Budesonide is indicated for conditions such as asthma (inhaled), chronic obstructive pulmonary disease (COPD), Crohn's disease (oral), ulcerative colitis (oral/rectal), eosinophilic esophagitis (oral suspension/tablet), primary immunoglobulin A nephropathy (oral delayed-release capsule), autoimmune hepatitis (oral capsule/granule), allergic rhinitis/nasal polyps (nasal spray), and microscopic colitis[1][2][3][4][5][6][7][8].

Brand names
PulmicortPulmicort FlexhalerPulmicort TurbuhalerPulmicort RespulesEntocort ECEohiliaOrtikosUcerisTarpeyoCortimentBudenofalkJorvezaRhinocort Aqua
Other names
budesónida
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on budesonide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on budesonide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call